287 related articles for article (PubMed ID: 25310743)
1. Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.
Sakthiswary R; D'Cruz D
Medicine (Baltimore); 2014 Oct; 93(16):e86. PubMed ID: 25310743
[TBL] [Abstract][Full Text] [Related]
2. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
Nieto-Aristizábal I; Martínez T; Urbano MA; Posso-Osorio I; Plata IF; Garcia-Robledo JE; Aragón CC; Santos VA; Tobón GJ
Lupus; 2019 Nov; 28(13):1566-1570. PubMed ID: 31653191
[TBL] [Abstract][Full Text] [Related]
3. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
[TBL] [Abstract][Full Text] [Related]
4. A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
Levy Y; Sherer Y; Ahmed A; Langevitz P; George J; Fabbrizzi F; Terryberry J; Meissner M; Lorber M; Peter JB; Shoenfeld Y
Lupus; 1999; 8(9):705-12. PubMed ID: 10602441
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
Zandman-Goddard G; Levy Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.
Martínez T; Garcia-Robledo JE; Plata I; Urbano MA; Posso-Osorio I; Rios-Serna LJ; Barrera MC; Tobón GJ
Autoimmun Rev; 2019 Mar; 18(3):279-286. PubMed ID: 30639648
[TBL] [Abstract][Full Text] [Related]
8. Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis.
Dai L; Chan KK; Mao JC; Tian Y; Gu JH; Zhou J; Zhong LLD
J Integr Med; 2020 Nov; 18(6):478-491. PubMed ID: 32907784
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
[TBL] [Abstract][Full Text] [Related]
11. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
Zandman-Goddard G; Blank M; Shoenfeld Y
Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
Sherer Y; Shoenfeld Y
Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
[TBL] [Abstract][Full Text] [Related]
14. Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
Merrill JT; Shanahan WR; Scheinberg M; Kalunian KC; Wofsy D; Martin RS
Ann Rheum Dis; 2018 Jun; 77(6):883-889. PubMed ID: 29563108
[TBL] [Abstract][Full Text] [Related]
15. Belimumab: review of use in systemic lupus erythematosus.
Boyce EG; Fusco BE
Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.
Lazurova I; Macejova Z; Benhatchi K; Oetterová M; Antolová E; Asherson RA; Rovensky J
Clin Rheumatol; 2007 Dec; 26(12):2145-2147. PubMed ID: 17487450
[TBL] [Abstract][Full Text] [Related]
17. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study.
Jiang Y; Zhao HJ; Luo H; Li BJ; Zhang ZM; Zhao LD; Zuo XX
Front Immunol; 2022; 13():861719. PubMed ID: 35757744
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus.
Shoenfeld Y; Rauova L; Gilburd B; Kvapil F; Goldberg I; Kopolovic J; Rovensky J; Blank M
Int Immunol; 2002 Nov; 14(11):1303-11. PubMed ID: 12407021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
